New guidelines from IDSA/SHEA highlight best practices for treating C difficile infection. Dr David Johnson provides insight for all providers who must be cognizant of this widespread problem.
Dr David J. Kerr discusses the difficult task of delivering bad news to patients--and their often paradoxical response--by sharing one of his favorite poems by Raymond Carver
Irreproducible results published in journals are misleading, irresponsible, and costly, and it is up to researchers and publishers to resolve this problem now.
Dr David Johnson on how to follow up initial discovery to determine whether what you're dealing with is benign, life-threatening, or something in between.
Dr David Johnson provides clinicians with an overview of the new guidelines from the American Association for the Study of Liver Diseases (AASLD) on hepatocellular carcinoma.
Dr David Johnson continues to provide his takeaways from this meeting. In part 2, study highlights from the biliary tract and pancreas to the small intestine and colon are covered.
Dr David Johnson provides his takeaways from this meeting. Part 1 reveals a 'wake-up call' for gastroenterologist burnout and updates in bariatric surgery, Barrett esophagus, G-POEM, NAFLD, and more.
A recent study relates future risk to current risk for advanced colorectal cancer. Dr Kerr suggests adding genetic testing to further improve diagnosis.
With the 'meteoric' rise of medicinal and recreational cannabinoid use, clinicians should be aware of this idiosyncratic gastrointestinal consequence of cannabinoids.